These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 21555633)

  • 21. [Don't let the patient with Parkinson's disease fall!].
    Bloem BR; Grimbergen YA; Roos RA
    Ned Tijdschr Geneeskd; 1998 Dec; 142(52):2825-7. PubMed ID: 10065254
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Akinetic crisis, acute akinesia, neuroleptic malignant-like syndrome, Parkinsonism-hyperpyrexia syndrome, and malignant syndrome are the same entity and are often independent of treatment withdrawal.
    Thomas A; Onofrj M
    Mov Disord; 2005 Dec; 20(12):1671; author reply 1671-2. PubMed ID: 16149099
    [No Abstract]   [Full Text] [Related]  

  • 23. Hyperpyrexia in the emergency department.
    McGugan EA
    Emerg Med (Fremantle); 2001 Mar; 13(1):116-20. PubMed ID: 11476402
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Neuroleptic malignant syndrome or parkinsonism hyperpyrexia syndrome.
    Granner MA; Wooten GF
    Semin Neurol; 1991 Sep; 11(3):228-35. PubMed ID: 1947485
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Recognizing Movement Disorder Emergencies - A Practical Review For Non-Neurologist.
    Hakeem H; Nasir M; Khan MF; Syed NM; Rajput HM; Ahmed A; Javed MA; Bhatti DE
    J Ayub Med Coll Abbottabad; 2019; 31(3):448-453. PubMed ID: 31535526
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Behavioral, neuropsychiatric and cognitive disorders in Parkinson's disease patients with and without motor complications.
    Solla P; Cannas A; Floris GL; Orofino G; Costantino E; Boi A; Serra C; Marrosu MG; Marrosu F
    Prog Neuropsychopharmacol Biol Psychiatry; 2011 Jun; 35(4):1009-13. PubMed ID: 21324349
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Psychotic symptoms in Parkinson's disease: pathophysiology and management.
    Bosboom JL; Wolters ECh
    Expert Opin Drug Saf; 2004 May; 3(3):209-20. PubMed ID: 15155149
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Common toxidromes in movement disorder neurology.
    Malek N; Baker MR
    Postgrad Med J; 2017 Jun; 93(1100):326-332. PubMed ID: 28546460
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The emerging role of clozapine in the treatment of movement disorders.
    Factor SA; Friedman JH
    Mov Disord; 1997 Jul; 12(4):483-96. PubMed ID: 9251065
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The neuroleptic malignant and serotonin syndromes.
    Carbone JR
    Emerg Med Clin North Am; 2000 May; 18(2):317-25, x. PubMed ID: 10767887
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hyperkinetic Movement Disorder Emergencies.
    Cossu G; Colosimo C
    Curr Neurol Neurosci Rep; 2017 Jan; 17(1):6. PubMed ID: 28168537
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Rhabdomyolysis in neuroleptic therapy: an abortive malignant neuroleptic syndrome?].
    Peschel O; Kurtz G; Müller-Felber W; Modell S
    Nervenarzt; 1994 Oct; 65(10):718-21. PubMed ID: 7808573
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Movement disorders with neuroleptic drug treatment.
    Tarsy D
    Psychiatr Clin North Am; 1984 Sep; 7(3):453-71. PubMed ID: 6148742
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Psychiatric Emergencies in the Intensive Care Unit.
    New AM; Nelson S; Leung JG
    AACN Adv Crit Care; 2015; 26(4):285-93; quiz 294-5. PubMed ID: 26484986
    [No Abstract]   [Full Text] [Related]  

  • 35. [Dantrolene in the treatment of life-threatening psychiatric disease pictures. A contribution to the therapy of the malignant neuroleptic syndrome and acute febrile catatonia].
    Schulte-Sasse U; Komar K; Eberlein HJ
    Dtsch Med Wochenschr; 1985 Mar; 110(12):457-61. PubMed ID: 3979279
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Neuroleptic malignant syndrome and acute life-threatening catatonia--two contrasting disease entities?].
    Heils A; Lesch KP
    Fortschr Neurol Psychiatr; 1997 Jan; 65(1):8-15. PubMed ID: 9132369
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Drug-induced hyperthermia in Huntington's disease.
    Gaasbeek D; Naarding P; Stor T; Kremer HP
    J Neurol; 2004 Apr; 251(4):454-7. PubMed ID: 15083292
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Emergency presentations of Parkinson's disease: early recognition and treatment are crucial for optimum outcome.
    Ghosh R; Liddle BJ
    Postgrad Med J; 2011 Feb; 87(1024):125-31. PubMed ID: 21106801
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Motor complications in Parkinson disease: clinical manifestations and management.
    Bhidayasiri R; Truong DD
    J Neurol Sci; 2008 Mar; 266(1-2):204-15. PubMed ID: 17897677
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neuroleptic malignant syndrome in a patient with Parkinson's disease: a case study.
    Ward C
    J Neurosci Nurs; 2005 Jun; 37(3):160-2. PubMed ID: 16001822
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.